Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer

Ernest S. Han, Robert A. Burger, Kathleen M. Darcy, Michael W. Sill, Leslie M. Randall, Dana Chase, Basmina Parmakhtiar, Bradley J. Monk, Benjamin E. Greer, Patrick Connelly, Koen Degeest, John P. Fruehauf

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences